Circulating Tumor DNA for Monitoring and Treatment in Metastatic Breast Cancer - 2024-25 EMBRACE Virtual Forum Series
Dana-Farber Cancer Institute via YouTube
Overview
Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Join breast medical oncologist Dr. Heather Parsons for a 56-minute presentation on circulating tumor DNA (ctDNA) in metastatic breast cancer as part of the 2024-25 EMBRACE MBC Virtual Forum Series. Learn about the latest research on ctDNA and discover how this technology can be used to monitor treatment response and guide treatment selection decisions for patients with metastatic breast cancer. The presentation provides valuable insights for understanding this emerging tool in cancer care and its potential applications in clinical practice.
Syllabus
Circulating Tumor DNA for Monitoring & Treatment in MBC | 2024-25 EMBRACE MBC Virtual Forum Series
Taught by
Dana-Farber Cancer Institute